Articles On EMvision Medical Devices (ASX:EMV)

HITIQ signs deal with English cricket EMVision gets $5m government grant ProMedicus signs new contracts in the US worth $16.5m Concussion tech specialist, HITIQ (ASX:HIQ) has renewed a subscription agreement with the English Cricket Broad...

EMVision Medical Devices (EMV) confirms the first two clinical sites for upcoming trials of its brain scanner product The company selected the Royal Melbourne Hospital in Victoria and Liverpool Hospital in NSW due to their specialisation i...

EMVision Medical Devices (EMV) receives a $600,000 milestone payment from the Australian Stroke Alliance (ASA) The payment is part of the Commonwealth of Australia Medical Research Future Fund program with the ASA for EMVision’s First Resp...

EMVision Medical Devices (ASX: EMV) has received a $600,000 payment after achieving an “important milestone” for its second-generation first responder stroke detection device. The payment comes from the Australian Stroke Alliance, as part o...

ASX is set to open sharply higher today after Friday’s big rally on Wall Street US major banks pass Fed’s “stress test” On the agenda this week includes OPEC+’s meeting Wall Street leapt higher on Friday, with banks leading the way as the...

ShareCafeWebinar Recap – EMV, KAL, TOR & TEM Catch up on the full webinar with presentations from EMVision (ASX: EMV), Kalgoorlie Gold Mining (ASX: KAL), Torque Metals (ASX: TOR) & Tempest Minerals (ASX: TEM) Webinar Recap – EMV,...

ShareCafeEMVision (ASX: EMV) – Webinar Presentation Scott Kirkland – Executive Director & Dr Ron Weinberger – CEO – EMVision is developing a portable brain scanner for rapid point of care Stroke Diagnosis and Monitoring. More EMVision...

The EMvision Medical Devices Ltd (ASX: EMV) share price rocketed today following news that the Australian Government will give the ASX company a multi-million dollar manufacturing grant. Shares in the Australian medical device company fini...

ShareCafeLunch Report: 18 May, 2022 by Melissa Darmawan   Materials lift ASX higher for 4th day Australian shares are on track to continue its winning streak for its fourth straight day after taking a strong lead from Wall St. The local ind...

EMVision Medical Devices (EMV) is awarded a grant under the Modern Manufacturing Initiative (MMI) program by the Department of Industry, Science, Energy and Resources The medical device company has been awarded $5 million under the MMI Man...

18 May 2022 - A snapshot of the stocks on the move featuring Eagers Automotive (ASX:APE), Boral (ASX:BLD) & EMVision Medical Devices (ASX:EMV).

Australian medtech EMVision Medical Devices (ASX: EMV) has been awarded $5 million in non-dilutive cash funding under the Australian Federal Government’s modern manufacturing initiative (MMI). The company is one of four businesses in New So...

Emerging markets index ends flat ASX200 0.5 higher Chinese economy hit by COVID-lockdowns   Anaemic data out of China has taken the fun out of Monday here in Sydney. April retail sales fell more than 11% year on year, almost twice what wa...

Emerging markets index ends flat ASX200 0.5 higher Chinese economy hit by COVID-lockdowns   Anaemic data out of China has taken the fun out of Monday here in Sydney. April retail sales fell more than 11% year on year, almost twice what wa...

The EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesday morning, and shot 8% into the green. Prior to their halt, EMVision shares closed at $1.94. Upon returning to trade, they have been sitti...

MedTech company EMVision (ASX: EMV) has signed an exclusive 12-month agreement with Keysight Technologies (NYSE: KEYS) for the use of its “fast sweep” technology, providing the business with a “substantial competitive advantage”. The deal...

EMVision Medical Devices (EMV) partners with Keysight Technologies Australia to continue developing a new generation of portable brain scanners The 12-month deal grants EMVision exclusivity to supply Keysight’s “fast sweep” feature in the...

Medical imaging technology company EMVision Medical Devices (ASX: EMV) has revealed it has secured a strategic deal with New York-listed Keysight Technologies (NYSE: KEYS) for the exclusive supply of “fast sweep” feature vector network anal...

EMVision Medical Devices (ASX: EMV) has announced its device development and multi-centre clinical trial preparation is progressing positively, with the company capping off its latest quarter being well funded. The company, as at 31 March 2...

The ASX 200 Health Index (XHJ) is up by 0.30% at the time of writing, compared to the broader index which is up by 0.60%. Clinical stage cannabis biotech, Emyria (ASX: EMD), announced that participant recruitment, screening and consenting h...

EmVision Medical Devices (EMV) has welcomed new members to its Clinical Advisory Board in an ex-officio capacity Professors Geoffrey Donnan and Stephan Davis, eminent neurologists and leaders in the field of stroke care, will join the EMVi...

Queensland-based EMVision Medical Devices (ASX: EMV) has added three respected experts in the field of stroke care to its clinical advisory board. Neurologists Professor Geoffrey Donnan and Professor Stephen Davis will join the board in an...

Medical imaging company EMVision Medical Devices (EMV) has continued to progress development and commercialisation of its portable brain scanner for stroke patients EMVision has finished the period with a strong cash balance of over $10.5...

EMVision Medical Devices (ASX: EMV) has continued advancing development and commercialisation plans of its portable brain scanner machine for stroke patients. During the half year ending December 2021 (H1 FY2022), EMVision progressed its po...

The ASX 200 Health Index (XHJ) is down by 0.20% at the time of writing, compared to the broader index which is down by 0.35%. Brain-focused company, Argenica Therapeutics (ASX:AGN), has just been awarded a US patent relating to the use of i...

EMVision Medical Devices (EMV) receives a total non-dilutive funding injection of $3.4 million Following several cash receipts the company has cash reserves of approximately $10.3 million Additional payments are reportedly still due to th...

The ASX returned to positive territory today as investors began to shrug off fears of the omicron variant, but the bourse is still well below levels seen last week. While utilities lost over 1%, most other sectors gained with telcos being t...

EMVision Medical Devices (EMV) spikes on the ASX after releasing further results from a pilot clinical trial of its brain scanning and stroke classification tech In a cohort of 50 patients, EMVision’s tech could classify strokes as haemorr...

EMVision (ASX:EMV) is developing a portable brain scanner called the 1st Gen, a device for use in ICUs, stroke and neurology wards, angiogram suites, and emergency departments, The underlying IP is the brainchild of a large team led by co-i...

After a positive start the ASX finished down over 0.5%. Today, APRA ordered the big banks to increase the home loan “serviceability buffer” from 2.5% to 3% from the end of October and hinted more regulation could be forthcoming. Also hittin...

The EMvision Medical Devices Ltd (ASX: EMV) share price has spent the morning in the red. It is currently changing hands for $2.91, down 5.21%. EMvision’s shares are on the move today after it announced an important update regarding a dev...

Wall Street rebounds US stocks staged a rebound overnight, following Monday’s tech-driven selloff. All three US stock market benchmarks rose – the Dow Jones up by 0.92%, the S&P 500 by 1.05% ,and tech heavy Nasdaq by 1.25%. Investors bo...

The ASX 200 health stocks index (XHJ) has lifted by 0.46% at the time of writing, compared to the broader ASX 200 index which rose by 0.73%. Mergers and acquisitions were very much the order of the day in the Health sector today. The countr...

The EMvision Medical Devices Ltd (ASX: EMV) share price is charging higher today. This follows the company providing an update in regard to its portable medical imaging technology. At the time of writing, shares in the medical device compa...

Summary A panic selling in oil and gold prices and concerns over the rapid spread of the Delta variant of coronavirus dented global sentiment. The market breadth is very positive with 10 out of the 11 sectors trading higher today. Cha...

The ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader index which rose by 0.35%. Medical imaging specialist, EMVision (ASX:EMV), has rocketed by 16% after announcing that 1st Gen portable brain scanner has...

Wall Street mixed as oil and metals fall US stock markets were mixed on Monday, as oil prices fell to a three-week low on concerns about the virus spread in China and the rising US dollar. The Dow Jones fell by 0.3%, S&P 500 down by 0.0...

The ASX Healthcare index rose by 0.45% this morning, compared with the broader index which fell by 0.80%, helped by medicinal cannabis company AusCann (ASX:AC8). It rose by 5% in morning trading. AusCann announced it has submitted the first...

Wall Street, Oil plunge on rising COVID cases All three benchmark indices in the US tumbled on Monday, as coronaviruses continue to spike around the world. The Dow Jones had its worst day this year, falling by 2.09%, S&P 500 by 1.59%, a...

The diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two technologies that have been around for decades. Although they have not been replaced entirely, a breed of new ASX small caps have emerged over...

Queensland-based EMVision Medical Devices (ASX: EMV) has reported significant advances to the design and engineering of its first-generation portable brain scanning machine prior to commercialisation. Improvements and upgrades have been mad...

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s b...

EMVision Medical Devices Ltd (ASX: EMV) shares were on the rise today following news of two significant technology and product development breakthroughs from the company. By the market’s close, the EMVision share price was trading at $3.16...

Portable brain scanning technology developed by EMVision Medical Devices (ASX: EMV) has been further enhanced by the addition of two new techniques with the potential to significantly improve the diagnosis and care of stroke patients. The c...

With health issues at the global forefront over the past year, it’s no surprise that Australia’s health-related sector has also grown substantially. But the industry was already emerging even before COVID-19. Excellent research facilities a...

The EMVision Medical Devices Ltd (ASX:EMV) share price is up more than 13%. After moving up the chart and going higher than $4 in November, the EMV share price fell away but is now pushing higher again today... The post EMvision Medical De...

The EMvision Medical Devices Ltd (ASX: EMV) share price closed 13.2% higher today after the company made a funding announcement. The EMvision share price finished off the trading session at $2.74 this afternoon. Here’s a wrap of where the...

Medical imaging technology company EMVision Medical Devices (ASX: EMV) is set to receive $8 million funding from a total $40 million pool awarded to commercial partner Australian Stroke Alliance (ASA) under the federal government’s Stage 2...

ASX health stocks EMvision (ASX:EMV) and 4D Medical (ASX:4DX) have been awarded over $37 million between them in government grants. ... Read More The post Another 2 ASX health stocks confirm they’ve received a major government grant appeare...

EMvision Medical Devices Ltd (ASX: EMV) shares are unchanged today after the company announced a trading halt before market open on Friday. At the close of market on Thursday, the EMVision share price was trading at $2.42.  Let’s take a lo...